| FENTANYL | ACTIVE MOIETY | UF599785JZ | Fentanyl Citrate 1 mcg/mL & Bupivacaine HCl 0.125% in 0.9% Sodium Chloride 100 mL Bag | 6 | |
| Fentanyl | ACTIVE MOIETY | UF599785JZ | Fentanyl Citrate 2 mcg/mL & Bupivacaine HCl 0.125% in 0.9% Sodium Chloride 100 mL Bag | 5 | |
| Fentanyl | ACTIVE MOIETY | UF599785JZ | Fentanyl Citrate 2 mcg/mL & Bupivacaine HCl 0.125% in 0.9% Sodium Chloride 125 mL Bag | 2 | |
| fentanyl | ACTIVE MOIETY | UF599785JZ | These highlights do not include all the information needed to use ABSTRAL safely and effectively. See full prescribing information for ABSTRAL. ABSTRAL ® (fentanyl) sublingual tablets CII Initial U.S. Approval: 1968 | 2 | |
| Fentanyl | ACTIVE MOIETY | UF599785JZ | Fentanyl Citrate 2 mcg/mL & Bupivacaine HCl 0.125% in 0.9% Sodium Chloride 250 mL Bag | 8 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | Fentanyl Citrate 5 mcg/mL in 0.9% Sodium Chloride 3 mL Syringe | 4 | |
| Fentanyl | ACTIVE MOIETY | UF599785JZ | Fentanyl Citrate 2 mcg/mL & Bupivacaine HCl 0.125% in 0.9% Sodium Chloride 250 mL Bag | 3 | |
| Fentanyl | ACTIVE MOIETY | UF599785JZ | Fentanyl Citrate 3 mcg/mL & Bupivacaine HCl 0.125% in 0.9% Sodium Chloride 200 mL Bag | 5 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | Fentanyl Citrate 20 mcg/mL in 0.9% Sodium Chloride 30 mL PCA Vial, Non-MedNet | 1 | |
| Fentanyl | ACTIVE MOIETY | UF599785JZ | Fentanyl Citrate 50 mcg/mL in Sterile Water 5 mL Syringe | 5 | |
| Fentanyl | ACTIVE MOIETY | UF599785JZ | Fentanyl Citrate 50 mcg/mL in Sterile Water 2 mL Syringe | 5 | |
| Fentanyl | ACTIVE MOIETY | UF599785JZ | Fentanyl Citrate 50 mcg/mL in Sterile Water 20 mL Syringe | 6 | |
| Fentanyl | ACTIVE MOIETY | UF599785JZ | Fentanyl Citrate 20 mcg/mL in 0.9% Sodium Chloride 100 mL Bag | 3 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | Fentanyl Citrate 20 mcg/mL in 0.9% Sodium Chloride 30 mL PCA Vial | 1 | |
| Fentanyl | ACTIVE MOIETY | UF599785JZ | These highlights do not include all the information needed to use LAZANDA safely and effectively. See full prescribing information for LAZANDA Lazanda ® (Fentanyl) Nasal Spray CII Initial U.S. Approval: 1968 | 5 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | These highlights do not include all the information needed to use ABSTRAL safely and effectively. See full prescribing information for ABSTRAL. ABSTRAL ® (fentanyl) sublingual tablets CII Initial U.S. Approval: 1968 | 3 | |
| FENTANYL | ACTIVE INGREDIENT | UF599785JZ | Fentanyl Transdermal System C-II Revised: August 2008 Rx only | 4 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | Fentanyl Transdermal System C-II Revised: August 2008 Rx only | 4 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL TRANSDERMAL SYSTEM CII | 3 | |
| FENTANYL | ACTIVE INGREDIENT | UF599785JZ | FENTANYL TRANSDERMAL SYSTEM CII | 3 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL TRANSDERMAL SYSTEM CII | 3 | |
| FENTANYL | ACTIVE INGREDIENT | UF599785JZ | FENTANYL TRANSDERMAL SYSTEM CII | 3 | |
| FENTANYL | ACTIVE INGREDIENT | UF599785JZ | FENTANYL TRANSDERMAL SYSTEM 25 mcg/hr, 50 mcg/hr, 75 mcg/hr, 100 mcg/hr CII Full Prescribing Information Rx only FOR USE IN OPIOID-TOLERANT PATIENTS ONLY | 1 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL TRANSDERMAL SYSTEM 25 mcg/hr, 50 mcg/hr, 75 mcg/hr, 100 mcg/hr CII Full Prescribing Information Rx only FOR USE IN OPIOID-TOLERANT PATIENTS ONLY | 1 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL TRANSDERMAL SYSTEM 25 mcg/hr, 50 mcg/hr, 75 mcg/hr, 100 mcg/hr CII Full Prescribing Information Rx only FOR USE IN OPIOID-TOLERANT PATIENTS ONLY | 1 | |
| FENTANYL | ACTIVE INGREDIENT | UF599785JZ | FENTANYL TRANSDERMAL SYSTEM 25 mcg/hr, 50 mcg/hr, 75 mcg/hr, 100 mcg/hr CII Full Prescribing Information Rx only FOR USE IN OPIOID-TOLERANT PATIENTS ONLY | 1 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | These highlights do not include all the information needed to use Oral Transmucosal Fentanyl Citrate (OTFC) safely and effectively. See full prescribing information for OTFC. Oral Transmucosal Fentanyl Citrate (OTFC) (fentanyl citrate) oral transmucosal lozenge, CII Initial U.S. Approval: 1968 | 1 | |
| Fentanyl | ACTIVE MOIETY | UF599785JZ | FENTANYL TRANSDERMAL SYSTEM CII | 1 | |
| Fentanyl | ACTIVE INGREDIENT | UF599785JZ | FENTANYL TRANSDERMAL SYSTEM CII | 1 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | These highlights do not include all the information needed to use Oral Transmucosal Fentanyl Citrate (OTFC) safely and effectively. See full prescribing information for OTFC. Oral Transmucosal Fentanyl Citrate (OTFC) (fentanyl citrate) oral transmucosal lozenge, CII Initial U.S. Approval: 1968 | 2 | |
| FENTANYL | ACTIVE INGREDIENT | UF599785JZ | FENTANYL TRANSDERMAL SYSTEM CII Rx only | 1 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL TRANSDERMAL SYSTEM CII Rx only | 1 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | b7fe401c-7ddc-4391-9cff-3608da03e86b | 2 | |
| FENTANYL | ACTIVE INGREDIENT | UF599785JZ | b7fe401c-7ddc-4391-9cff-3608da03e86b | 2 | |
| fentanyl | ACTIVE MOIETY | UF599785JZ | SUBLIMAZE ® Injection CII | 1 | |
| FENTANYL | ACTIVE INGREDIENT | UF599785JZ | FENTANYL PATCH, EXTENDED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3444 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL PATCH, EXTENDED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3444 | |
| FENTANYL | ACTIVE INGREDIENT | UF599785JZ | FENTANYL PATCH, EXTENDED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3443 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL PATCH, EXTENDED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3443 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL PATCH, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1002 | |
| FENTANYL | ACTIVE INGREDIENT | UF599785JZ | FENTANYL PATCH, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1002 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL PATCH, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1001 | |
| FENTANYL | ACTIVE INGREDIENT | UF599785JZ | FENTANYL PATCH, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1001 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL PATCH, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1001 | |
| FENTANYL | ACTIVE INGREDIENT | UF599785JZ | FENTANYL PATCH, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1001 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL TRANSDERMAL SYSTEM PATCH, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1001 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL TRANSDERMAL SYSTEM PATCH, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1001 | |
| FENTANYL | ACTIVE INGREDIENT | UF599785JZ | FENTANYL TRANSDERMAL SYSTEM PATCH, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1001 | |
| FENTANYL | ACTIVE INGREDIENT | UF599785JZ | FENTANYL TRANSDERMAL SYSTEM PATCH, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1001 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL TRANSDERMAL SYSTEM PATCH, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1001 | |
| FENTANYL | ACTIVE INGREDIENT | UF599785JZ | FENTANYL TRANSDERMAL SYSTEM PATCH, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1001 | |
| FENTANYL | ACTIVE INGREDIENT | UF599785JZ | FENTANYL PATCH [BRYANT RANCH PREPACK] | 1000 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL PATCH [BRYANT RANCH PREPACK] | 1000 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL PATCH, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| FENTANYL | ACTIVE INGREDIENT | UF599785JZ | FENTANYL PATCH, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL PATCH, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL PATCH, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| FENTANYL | ACTIVE INGREDIENT | UF599785JZ | FENTANYL PATCH, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL PATCH, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| FENTANYL | ACTIVE INGREDIENT | UF599785JZ | FENTANYL PATCH, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL PATCH, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| FENTANYL | ACTIVE INGREDIENT | UF599785JZ | FENTANYL PATCH, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL PATCH, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| FENTANYL | ACTIVE INGREDIENT | UF599785JZ | FENTANYL PATCH, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| FENTANYL | ACTIVE INGREDIENT | UF599785JZ | FENTANYL PATCH, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL PATCH, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| FENTANYL | ACTIVE INGREDIENT | UF599785JZ | FENTANYL PATCH, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| FENTANYL | ACTIVE INGREDIENT | UF599785JZ | FENTANYL PATCH, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL PATCH, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| FENTANYL | ACTIVE INGREDIENT | UF599785JZ | FENTANYL TRANSDERMAL SYSTEM PATCH, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL TRANSDERMAL SYSTEM PATCH, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL TRANSDERMAL SYSTEM PATCH, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL TRANSDERMAL SYSTEM PATCH, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| FENTANYL | ACTIVE INGREDIENT | UF599785JZ | FENTANYL TRANSDERMAL SYSTEM PATCH, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL TRANSDERMAL SYSTEM PATCH, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| FENTANYL | ACTIVE INGREDIENT | UF599785JZ | FENTANYL TRANSDERMAL SYSTEM PATCH, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| FENTANYL | ACTIVE INGREDIENT | UF599785JZ | FENTANYL TRANSDERMAL SYSTEM PATCH, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL PATCH, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 26 | |
| FENTANYL | ACTIVE INGREDIENT | UF599785JZ | FENTANYL PATCH, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 26 | |
| FENTANYL | ACTIVE INGREDIENT | UF599785JZ | FENTANYL TRANSDERMAL SYSTEM PATCH, EXTENDED RELEASE [MALLINCKRODT, INC.] | 25 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL TRANSDERMAL SYSTEM PATCH, EXTENDED RELEASE [MALLINCKRODT, INC.] | 25 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL CITRATE INJECTION, SOLUTION [HOSPIRA, INC.] | 16 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL CITRATE LOZENGE [CIMA LABS INC.] | 12 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | SUBSYS (FENTANYL) SPRAY [INSYS THERAPEUTICS, INC.] | 12 | |
| FENTANYL | ACTIVE INGREDIENT | UF599785JZ | SUBSYS (FENTANYL) SPRAY [INSYS THERAPEUTICS, INC.] | 12 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL CITRATE (FENTANYL CITRATE ) LOZENGE [MALLINCKRODT INC.] | 11 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL CITRATE INJECTION, SOLUTION [HOSPIRA, INC.] | 11 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTORA (FENTANYL CITRATE) TABLET [CEPHALON, INC.] | 10 | |
| FENTANYL | ACTIVE INGREDIENT | UF599785JZ | FENTANYL PATCH [MYLAN PHARMACEUTICALS INC.] | 9 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL PATCH [MYLAN PHARMACEUTICALS INC.] | 9 | |
| fentanyl | ACTIVE INGREDIENT | UF599785JZ | DURAGESIC (FENTANYL) PATCH [JANSSEN PHARMACEUTICALS, INC.] | 8 | |
| fentanyl | ACTIVE MOIETY | UF599785JZ | DURAGESIC (FENTANYL) PATCH [JANSSEN PHARMACEUTICALS, INC.] | 8 | |
| Fentanyl | ACTIVE MOIETY | UF599785JZ | FENTANYL PATCH [SANDOZ,INC.] | 8 | |
| Fentanyl | ACTIVE INGREDIENT | UF599785JZ | FENTANYL PATCH [SANDOZ,INC.] | 8 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | ACTIQ (FENTANYL CITRATE) LOZENGE [CEPHALON, INC.] | 7 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 7 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 6 | |
| Fentanyl | ACTIVE INGREDIENT | UF599785JZ | FENTANYL PATCH, EXTENDED RELEASE [UPSHER-SMITH LABORATORIES, INC.] | 6 | |
| Fentanyl | ACTIVE MOIETY | UF599785JZ | FENTANYL PATCH, EXTENDED RELEASE [UPSHER-SMITH LABORATORIES, INC.] | 6 | |
| FENTANYL | ACTIVE INGREDIENT | UF599785JZ | FENTANYL - NOVAPLUS (FENTANYL) PATCH, EXTENDED RELEASE [WATSON LABORATORIES, INC.] | 5 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL - NOVAPLUS (FENTANYL) PATCH, EXTENDED RELEASE [WATSON LABORATORIES, INC.] | 5 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL BUCCAL TABLET [WATSON LABORATORIES, INC.] | 5 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 5 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 5 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 5 | |
| FENTANYL | ACTIVE INGREDIENT | UF599785JZ | FENTANYL PATCH, EXTENDED RELEASE [APOTEX CORP.] | 5 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL PATCH, EXTENDED RELEASE [APOTEX CORP.] | 5 | |
| Fentanyl | ACTIVE MOIETY | UF599785JZ | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 4 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 4 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 4 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 4 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 4 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL CITRATE LOZENGE [PAR PHARMACEUTICAL INC.] | 4 | |
| FENTANYL | ACTIVE INGREDIENT | UF599785JZ | FENTANYL PATCH [PAR PHARMACEUTICAL INC.] | 4 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL PATCH [PAR PHARMACEUTICAL INC.] | 4 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL PATCH, EXTENDED RELEASE [APOTEX CORP.] | 4 | |
| FENTANYL | ACTIVE INGREDIENT | UF599785JZ | FENTANYL PATCH, EXTENDED RELEASE [APOTEX CORP.] | 4 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL CITRATE INJECTION [AKORN, INC.] | 3 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL CITRATE INJECTION, SOLUTION [BAXTER HEALTHCARE CORPORATION] | 3 | |
| Fentanyl | ACTIVE MOIETY | UF599785JZ | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 3 | |